BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24306456)

  • 1. A mild removal of Fmoc group using sodium azide.
    Chen CC; Rajagopal B; Liu XY; Chen KL; Tyan YC; Lin F; Lin PC
    Amino Acids; 2014 Feb; 46(2):367-74. PubMed ID: 24306456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.
    Ruczyński J; Lewandowska B; Mucha P; Rekowski P
    J Pept Sci; 2008 Mar; 14(3):335-41. PubMed ID: 17975850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide thioester preparation by Fmoc solid phase peptide synthesis for use in native chemical ligation.
    Clippingdale AB; Barrow CJ; Wade JD
    J Pept Sci; 2000 May; 6(5):225-34. PubMed ID: 10823491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing aspartimide formation in Fmoc SPPS of Asp-Gly containing peptides--practical aspects of new trialkylcarbinol based protecting groups.
    Behrendt R; Huber S; White P
    J Pept Sci; 2016 Feb; 22(2):92-7. PubMed ID: 26751703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.
    Fields CG; VanDrisse VL; Fields GB
    Pept Res; 1993; 6(1):39-47. PubMed ID: 8439735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic procedure for N-Fmoc amino acyl-N-sulfanylethylaniline linker as crypto-peptide thioester precursor with application to native chemical ligation.
    Sakamoto K; Sato K; Shigenaga A; Tsuji K; Tsuda S; Hibino H; Nishiuchi Y; Otaka A
    J Org Chem; 2012 Aug; 77(16):6948-58. PubMed ID: 22816612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aspartimide problem in Fmoc-based SPPS. Part III.
    Mergler M; Dick F
    J Pept Sci; 2005 Oct; 11(10):650-7. PubMed ID: 15849777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New t-butyl based aspartate protecting groups preventing aspartimide formation in Fmoc SPPS.
    Behrendt R; Huber S; Martí R; White P
    J Pept Sci; 2015 Aug; 21(8):680-7. PubMed ID: 26077723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.
    Gross CM; Lelièvre D; Woodward CK; Barany G
    J Pept Res; 2005 Mar; 65(3):395-410. PubMed ID: 15787970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Fmoc solid-phase peptide synthesis.
    Behrendt R; White P; Offer J
    J Pept Sci; 2016 Jan; 22(1):4-27. PubMed ID: 26785684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis.
    Palasek SA; Cox ZJ; Collins JM
    J Pept Sci; 2007 Mar; 13(3):143-8. PubMed ID: 17121420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handles for Fmoc solid-phase synthesis of protected peptides.
    Góngora-Benítez M; Tulla-Puche J; Albericio F
    ACS Comb Sci; 2013 May; 15(5):217-28. PubMed ID: 23573835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-(N-Fmoc)-3-(N-Boc-N-methoxy)-diaminopropanoic acid, an amino acid for the synthesis of mimics of O-linked glycopeptides.
    Carrasco MR; Brown RT; Doan VH; Kandel SM; Lee FC
    Biopolymers; 2006; 84(4):414-20. PubMed ID: 16508952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprotection Reagents in Fmoc Solid Phase Peptide Synthesis: Moving Away from Piperidine?
    Luna OF; Gomez J; Cárdenas C; Albericio F; Marshall SH; Guzmán F
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27854291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase synthesis of "mixed" peptidomimetics using Fmoc-protected aza-beta3-amino acids and alpha-amino acids.
    Busnel O; Bi L; Dali H; Cheguillaume A; Chevance S; Bondon A; Muller S; Baudy-Floc'h M
    J Org Chem; 2005 Dec; 70(26):10701-8. PubMed ID: 16355988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of C-terminal peptide thioesters using Fmoc-based solid-phase peptide chemistry.
    Shelton PT; Jensen KJ
    Methods Mol Biol; 2013; 1047():119-29. PubMed ID: 23943482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The aspartimide problem in Fmoc-based SPPS. Part I.
    Mergler M; Dick F; Sax B; Weiler P; Vorherr T
    J Pept Sci; 2003 Jan; 9(1):36-46. PubMed ID: 12587881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydropyranyl, a nonaromatic acid-labile Cys protecting group for Fmoc peptide chemistry.
    Ramos-Tomillero I; Rodríguez H; Albericio F
    Org Lett; 2015 Apr; 17(7):1680-3. PubMed ID: 25764355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of glyoxylyl peptides using an Fmoc-protected alpha,alpha'-diaminoacetic acid derivative.
    Far S; Melnyk O
    J Pept Sci; 2005 Jul; 11(7):424-30. PubMed ID: 15641117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of in situ silylation for improved, convenient preparation of fluorenylmethoxycarbonyl (Fmoc)-protected phosphinate amino acids.
    Li S; Whitehead JK; Hammer RP
    J Org Chem; 2007 Apr; 72(8):3116-8. PubMed ID: 17375960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.